{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:31:53Z","timestamp":1784921513409,"version":"3.55.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Maturity-onset diabetes of the young type 5 (MODY 5) is a form of monogenic diabetes that is often accompanied by pancreatic dysfunction. To date, no cases of MODY 5 treated with glucagon-like peptide-1 receptor agonist (GLP-1RA) have been reported. We present the first case of MODY 5 treated with GLP-1RA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 17-year-old woman, with a history of being operated for congenital ileal atresia at birth, was admitted to our hospital due to hyperglycemia. She had been clinically diagnosed with type 1 diabetes 1 month prior, and administered 14 units of insulin glargine 300\u200aU\/mL per day.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>She had hypopotassemia, hypomagnesaemia, pancreatic body, and tail defects, multiple renal cysts, and a family history of diabetes, and urogenital anomaly. Genetic testing revealed heterozygous deletion of hepatocyte nuclear transcription factor-1 beta, leading to the diagnosis of MODY 5.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was treated with multiple daily insulin injections for 9 days (22\u200aunits\/d) before administration of GLP-1RA, and then liraglutide was initiated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Liraglutide treatment (0.6\u200amg\/d) alone maintained the patient's glycated hemoglobin level below 7.0% for at least 12 months after discharge. A higher dose, 0.9\u200amg\/d, of liraglutide was not tolerated by the patient due to nausea. Serum levels of C-peptide immunoreactivity were 1.15\u200ang\/mL and 1.91\u200ang\/mL, respectively, after 6 and 12 months of liraglutide therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>GLP-1RA might be effective at regulating glucose metabolism by utilizing residual pancreatic endocrine function in patients with MODY 5. Imaging and genetic screening were helpful in the diagnosis of MODY 5.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021939","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T17:02:30Z","timestamp":1598461350000},"page":"e21939","source":"Crossref","is-referenced-by-count":16,"title":["Maturity-Onset diabetes of the young type 5 treated with the glucagon-like peptide-1 receptor agonist"],"prefix":"10.1097","volume":"99","author":[{"given":"Aiko","family":"Terakawa","sequence":"first","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7727-6310","authenticated-orcid":false,"given":"Daisuke","family":"Chujo","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo"},{"name":"Center for Clinical Research, Toyama University Hospital, Toyama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo"},{"name":"Department of Diabetes, Endocrinology and Metabolism, Kyorin University, Mitaka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Tokyo Shinjuku Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoka","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Hamano","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo"},{"name":"Mishuku Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Ohsugi","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyo","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohjiro","family":"Ueki","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kajio","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajhg.2015.05.011","article-title":"Loss-of-function mutations in APPL1 in familial diabetes mellitus","volume":"97","author":"Prudente","year":"2015","journal-title":"Am J Hum Genet"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/ng1297-384","article-title":"Mutation in hepatocyte nuclear factor-1beta gene (TCF2) associated with MODY","volume":"17","author":"Horikawa","year":"1997","journal-title":"Nat Genet"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"510","DOI":"10.7326\/0003-4819-140-7-200404060-00009","article-title":"Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations","volume":"140","author":"Bellann\u00e9-Chantelot","year":"2004","journal-title":"Ann Intern Med"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1464-5491.2008.02460.x","article-title":"Lack of pancreatic body and tail in HNF1B mutation carriers","volume":"25","author":"Haldorsen","year":"2008","journal-title":"Diabetes Med"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1046\/j.1523-1755.2002.00272.x","article-title":"Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1beta mutations","volume":"61","author":"Bingham","year":"2002","journal-title":"Kidney Int"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/ki.2011.225","article-title":"Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood","volume":"80","author":"Faguer","year":"2011","journal-title":"Kidney Int"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/jmg.2005.032854","article-title":"Mutations in hepatocyte nuclear factor-1beta and their related phenotypes","volume":"43","author":"Edghill","year":"2006","journal-title":"J Med Genet"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1681\/ASN.2008060633","article-title":"HNF1B mutations associate with hypomagnesemia and renal magnesium wasting","volume":"20","author":"Adalat","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.2337\/diacare.21.12.2144","article-title":"Liver and kidney function in Japanese patients with maturity-onset diabetes of the young","volume":"21","author":"Iwasaki","year":"1998","journal-title":"Diabetes Care"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.diabet.2016.10.003","article-title":"Intellectual disability in patients with MODY due to hepatocyte nuclear factor 1B (HNF1B) molecular defects","volume":"43","author":"Dubois-Laforgue","year":"2017","journal-title":"Diabetes Metab"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jdiacomp.2018.12.013","article-title":"Liraglutide prevents \u00df-cell apoptosis via inactivation of NOX2 and its related signalling pathway","volume":"33","author":"Ding","year":"2019","journal-title":"J Diabetes Complications"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1111\/jcmm.13259","article-title":"Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic \u00df-cell apoptosis","volume":"22","author":"Kapodistria","year":"2018","journal-title":"J Cell Mol Med"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.2337\/dc11-0035","article-title":"MODY: history, genetics, pathophysiology, and clinical decision making","volume":"34","author":"Fajans","year":"2011","journal-title":"Diabetes Care"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/pedi.12766","article-title":"Comprehensive genetic screening: the prevalence of maturity-onset diabetes of the young gene variants in a population-based childhood diabetes cohort","volume":"20","author":"Johnson","year":"2019","journal-title":"Pediatr Diabetes"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/jdi.12812","article-title":"Maturity-onset diabetes of the young as a model for elucidating the multifactorial origin of type 2 diabetes mellitus","volume":"9","author":"Horikawa","year":"2018","journal-title":"J Diabetes Investig"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1681\/ASN.2006091057","article-title":"Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys","volume":"18","author":"Decramer","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1681\/ASN.2005101040","article-title":"Renal phenotype related to hepatocyte nuclear factor-1beta (TCF2) mutations in a pediatric cohort","volume":"17","author":"Ulinski","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2337\/dc16-2462","article-title":"Diabetes, associated clinical spectrum, long-term prognosis, and genotype\/phenotype correlations in 201 adult patients with hepatocyte nuclear factor 1B (HNF1B) molecular defects","volume":"40","author":"Dubois-Laforgue","year":"2017","journal-title":"Diabetes Care"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.kint.2016.03.027","article-title":"Chromosome 17q12 microdeletions but not intragenic HNF1B mutations link developmental kidney disease and psychiatric disorder","volume":"90","author":"Clissold","year":"2016","journal-title":"Kidney Int"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2215\/CJN.06810909","article-title":"Spectrum of HNF1B mutations in a large cohort of patients who harbour renal diseases","volume":"5","author":"Heidet","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ajhg.2010.10.004","article-title":"Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia","volume":"87","author":"Moreno-De-Luca","year":"2010","journal-title":"Am J Hum Genet"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/jdi.13004","article-title":"Phenotypic differences and similarities of monozygotic twins with maturity-onset diabetes of the young type 5","volume":"10","author":"Ohara","year":"2019","journal-title":"J Diabetes Investig"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/dme.12416","article-title":"Screening of diabetes of youth for hepatocyte nuclear factor 1 mutations: clinical phenotype of HNF1\u00df-related maturity-onset diabetes of the young and HNF1\u03b1-related maturity-onset diabetes of the young in Japanese","volume":"31","author":"Horikawa","year":"2014","journal-title":"Diabet Med"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1399-5448.2011.00827.x","article-title":"Comprehensive molecular analysis of Japanese patients with pediatric-onset MODY-type diabetes mellitus","volume":"13","author":"Yorifuji","year":"2012","journal-title":"Pediatr Diabetes"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1210\/jc.2018-00955","article-title":"17q12 deletion syndrome as a rare cause for diabetes mellitus type MODY 5","volume":"103","author":"Roehlen","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1210\/en.2004-0281","article-title":"Selective deletion of the Hnf1beta (MODY5) gene in beta-cells leads to altered gene expression and defective insulin release","volume":"145","author":"Wang","year":"2004","journal-title":"Endocrinology"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/diabetes.55.02.06.db05-1019","article-title":"Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and -1alpha mutations diabetes","volume":"55","author":"Brackenridge","year":"2006","journal-title":"Diabetes"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.12659\/MSM.907227","article-title":"Comparative Study of liraglutide and insulin glargine on glycemic control and pancreatic \u00df-cell function in db\/db mice","volume":"24","author":"Li","year":"2018","journal-title":"Med Sci Monit"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.stemcr.2016.01.007","article-title":"Early developmental perturbations in a human stem cell model of MODY5\/HNF1B pancreatic hypoplasia","volume":"6","author":"Teo","year":"2016","journal-title":"Stem Cell Rep"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ydbio.2004.01.040","article-title":"Conditional inactivation of Pax6 in the pancreas causes early onset of diabetes","volume":"269","author":"Ashery-Padan","year":"2004","journal-title":"Dev Biol"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1172\/JCI88015","article-title":"PAX6 maintains \u00df cell identity by repressing genes of alternative islet cell types","volume":"127","author":"Swisa","year":"2017","journal-title":"J Clin Invest"},{"key":"R32-20230915","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature11793","article-title":"Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b","volume":"494","author":"Kornfeld","year":"2013","journal-title":"Nature"},{"key":"R33-20230915","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.freeradbiomed.2017.09.016","article-title":"Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4\/NOX1-mediated regulation of superoxide","volume":"113","author":"Long","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"R34-20230915","first-page":"7372","article-title":"Liraglutide improves hepatic insulin resistance via the canonical Wnt signaling pathway","volume":"17","author":"Qin","year":"2018","journal-title":"Mol Med Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:57:54Z","timestamp":1694825874000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021939"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":34,"journal-issue":{"issue":"35","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021939","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,28]]}}}